Lymphoma
Updated: 07/24/2007

References

Anderson GD, Rosito G et al. Drug interaction potential of soy extract and Panax ginseng. J Clin Pharmacol . 2003 Jun;43(6):643-8.

Arditti FD, Rabinkov A et al. Apoptotic killing of B-chronic lymphocytic leukemia tumor cells by allicin generated in situ using a rituximab-alliinase conjugate. Mol Cancer Ther . 2005 Feb;4(2):325-31.

Ashfaq MK, Zuberi HS et al. Vitamin E and beta-carotene affect natural killer cell function. Int J Food Sci Nutr . 2000;51 Suppl:S13-S20.

Baris D, Zahm SH. Epidemiology of lymphomas. Curr Opin Oncol . 2000 Sep;12(5):383-94.

Baxa DM, Yoshimura FK. Genistein reduces NF-kappa B in T lymphoma cells via a caspase-mediated cleavage of I kappa B alpha. Biochem Pharmacol . 2003 Sep 15;66(6):1009-18.

Bertolini F, Fusetti L et al. Inhibition of angiogenesis and induction of endothelial and tumor cell apoptosis by green tea in animal models of human high-grade non-Hodgkin's lymphoma. Leukemia . 2000 Aug;14(8):1477-82.

Betz O, Kranke P et al. [Is ginger a clinically relevant antiemetic? A systematic review of randomized controlled trials]. Forsch Komplementarmed Klass Naturheilkd . 2005 Feb;12(1):14-23.

Brauninger A, Hansmann ML et al. Identification of common germinal-center B-cell precursors in two patients with both Hodgkin's disease and non-Hodgkin's lymphoma. N Engl J Med . 1999 Apr 22;340(16):1239-47.

Bruno R, Ghisolfi L et al. Wine and tumors: study of resveratrol. Drugs Exp Clin Res . 2003;29(5-6):257-61.

Buckley AR, Buckley DJ et al. Inhibition by genistein of prolactin-induced Nb2 lymphoma cell mitogenesis. Mol Cell Endocrinol . 1993 Dec;98(1):17-25.

Buckley R, Shewring B et al. Circulating triacylglycerol and apoE levels in response to EPA and docosahexaenoic acid supplementation in adult human subjects. Br J Nutr . 2004 Sep;92(3):477-83.

Calder PC, Yaqoob P et al. Fatty acids and lymphocyte functions. Br J Nutr . 2002 Jan;87 Suppl 1:S31-S48.

Canellos GP. Lymphoma: present and future challenges. Semin Hematol . 2004 Oct;41(4 Suppl 7):26-31.

Cartwright RA, Gurney KA et al. Sex ratios and the risks of haematological malignancies. Br J Haematol . 2002 Sep;118(4):1071-7.

Catassi C, Fabiani E et al. Risk of non-Hodgkin lymphoma in celiac disease. JAMA . 2002 Mar 20;287(11):1413-9.

Cerhan JR. New epidemiologic leads in the etiology of non-Hodgkin lymphoma in the elderly: the role of blood transfusion and diet. Biomed Pharmacother . 1997a;51(5):200-7.

Cerhan JR, Anderson KE et al. Association of aspirin and other non-steroidal anti-inflammatory drug use with incidence of non-Hodgkin lymphoma. Int J Cancer . 2003 Sep 20;106(5):784-8.

Cerhan JR, Vachon CM et al. Hormone replacement therapy and risk of non-hodgkin lymphoma and chronic lymphocytic leukemia. Cancer Epidemiol Biomarkers Prev . 2002 Nov;11(11):1466-71.

Cerhan JR, Wallace RB et al. Medical history risk factors for non-Hodgkin's lymphoma in older women. J Natl Cancer Inst . 1997b Feb 19;89(4):314-8.

Chanan-Khan A. Bcl-2 antisense therapy in hematologic malignancies. Curr Opin Oncol . 2004 Nov;16(6):581-5.

Chang ET, Smedby KE et al. Dietary factors and risk of non-hodgkin lymphoma in men and women. Cancer Epidemiol Biomarkers Prev . 2005 Feb;14(2):512-20.

Chatta GS, Dale DC. Aging and haemopoiesis. Implications for treatment with haemopoietic growth factors. Drugs Aging . 1996 Jul;9(1):37-47.

Chen Q, Espey MG et al. Pharmacologic ascorbic acid concentrations selectively kill cancer cells: action as a pro-drug to deliver hydrogen peroxide to tissues. Proc Natl Acad Sci U S A . 2005 Sep 20;102(38):13604-9.

Chiu BC, Cerhan JR et al. Diet and risk of non-Hodgkin lymphoma in older women. JAMA . 1996 May 1;275(17):1315-21.

Coffey J, Hodgson DC et al. Therapy of non-Hodgkin's lymphoma. Eur J Nucl Med Mol Imaging . 2003 Jun;30 Suppl 1:S28-S36.

Dalen H, Neuzil J. Alpha-tocopheryl succinate sensitises a T lymphoma cell line to TRAIL-induced apoptosis by suppressing NF-kappaB activation. Br J Cancer . 2003a Jan 13;88(1):153-8.

Dalen H, Neuzil J. Alpha-tocopheryl succinate sensitises a T lymphoma cell line to TRAIL-induced apoptosis by suppressing NF-kappaB activation. Br J Cancer . 2003b Jan 13;88(1):153-8.

Danese C, Angrisani L et al. [A five year follow-up of a Primary Effusion Lymphoma HHV-8 related in an HIV-negative elderly patient]. Clin Ter . 2004 Nov;155(11-12):543-6.

Dasgupta J, Sanyal U et al. Vitamin E--its status and role in leukemia and lymphoma. Neoplasma . 1993;40(4):235-40.

De SE, Fierro L et al. Tobacco, alcohol, diet and risk of non-Hodgkin's lymphoma: a case-control study in Uruguay. Leuk Res . 1998 May;22(5):445-52.

DeNardo GL. Concepts in radioimmunotherapy and immunotherapy: Radioimmunotherapy from a Lym-1 perspective. Semin Oncol . 2005 Feb;32(1 Suppl 1):S27-S35.

Dillman RO. Radioimmunotherapy of relapsed or refractory low-grade, follicular, or transformed B-cell non-Hodgkin's lymphoma. Curr Hematol Rep . 2003 Jan;2(1):30-7.

Dulak J. Nutraceuticals as anti-angiogenic agents: hopes and reality. J Physiol Pharmacol . 2005 Mar;56 Suppl 1:51-69.

Escalon MP, Liu NS et al. Prognostic factors and treatment of patients with T-cell non-Hodgkin lymphoma. Cancer . 2005 May 15;103(10):2091-8.

Feugier P, Van HA et al. Long-term results of the R-CHOP study in the treatment of elderly patients with diffuse large B-cell lymphoma: a study by the Groupe d'Etude des Lymphomes de l'Adulte. J Clin Oncol . 2005 May 2.

Fiorilli M, Mecucci C et al. HCV-associated lymphomas. Rev Clin Exp Hematol . 2003 Dec;7(4):406-23.

Fisher SG, Fisher RI. The epidemiology of non-Hodgkin's lymphoma. Oncogene . 2004 Aug 23;23(38):6524-34.

Floret N, Mauny F et al. Dioxin emissions from a solid waste incinerator and risk of non-Hodgkin lymphoma. Epidemiology . 2003 Jul;14(4):392-8.

Forero A, Lobuglio AF. History of antibody therapy for non-Hodgkin's lymphoma. Semin Oncol . 2003 Dec;30(6 Suppl 17):1-5.

Franco M, Rugge M et al. Gastric mucosa-associated lymphoid tissue lymphoma and Helicobacter pylori: scratch and win. Scand J Gastroenterol . 2005 Jan;40(1):115-9.

Freedman DM, Cantor KP et al. A case-control study of nitrate in drinking water and non-Hodgkin's lymphoma in Minnesota. Arch Environ Health . 2000 Sep;55(5):326-9.

Gaisbauer M, Langosch A. [Raw food and immunity]. Fortschr Med . 1990 Jun 10;108(17):338-40.

Gescher A. Polyphenolic phytochemicals versus non-steroidal anti-inflammatory drugs: which are better cancer chemopreventive agents? J Chemother . 2004 Nov;16 Suppl 4:3-6.

Giannoulis E, Economopoulos T et al. The prevalence of hepatitis C and hepatitis G virus infection in patients with B cell non-Hodgkin lymphomas in Greece: a Hellenic Cooperative Oncology Group Study. Acta Haematol . 2004;112(4):189-93.

Glaser SL. Black-white differences in Hodgkin's disease incidence in the United States by age, sex, histology subtype and time. Int J Epidemiol . 1991 Mar;20(1):68-75.

Grillo-Lopez AJ. 90Y-ibritumomab tiuxetan: rationale for patient selection in the treatment of indolent non-Hodgkin's lymphoma. Semin Oncol . 2005 Feb;32(1 Suppl 1):S44-S49.

Groves FD, Linet MS et al. Cancer surveillance series: non-Hodgkin's lymphoma incidence by histologic subtype in the United States from 1978 through 1995. J Natl Cancer Inst . 2000 Aug 2;92(15):1240-51.

Hagenbeek A. Future trends in radioimmunotherapy. Semin Oncol . 2005 Feb;32(1 Suppl 1):S57-S62.

Han SS, Chung ST et al. Curcumin causes the growth arrest and apoptosis of B cell lymphoma by downregulation of egr-1, c-myc, bcl-XL, NF-kappa B, and p53. Clin Immunol . 1999 Nov;93(2):152-61.

Hansmann ML, Kuppers R. Pathology and "molecular histology" of Hodgkin's disease and the border to non-Hodgkin's lymphomas. Baillieres Clin Haematol . 1996 Sep;9(3):459-77.

Harris NL. Hodgkin's disease: classification and differential diagnosis. Mod Pathol . 1999 Feb;12(2):159-75.

Hauke RJ, Armitage JO. A new approach to non-Hodgkin's lymphoma. Intern Med . 2000 Mar;39(3):197-208.

Heimli H, Finstad HS et al. Necrosis and apoptosis in lymphoma cell lines exposed to eicosapentaenoic acid and antioxidants. Lipids . 2001 Jun;36(6):613-21.

Heimli H, Giske C et al. Eicosapentaenoic acid promotes apoptosis in Ramos cells via activation of caspase-3 and -9. Lipids . 2002 Aug;37(8):797-802.

Heimli H, Hollung K et al. Eicosapentaenoic acid-induced apoptosis depends on acyl CoA-synthetase. Lipids . 2003 Mar;38(3):263-8.

Holmes FF, Wilson J et al. Biology of cancer and aging. Cancer . 1991 Dec 1;68(11 Suppl):2525-6.

Iarussi D, Auricchio U et al. Protective effect of coenzyme Q10 on anthracyclines cardiotoxicity: control study in children with acute lymphoblastic leukemia and non-Hodgkin lymphoma. Mol Aspects Med . 1994;15 Suppl:s207-s212.

Irwin D, Kaplan L. Clinical aspects of HIV-related lymphoma. Curr Opin Oncol . 1993 Sep;5(5):852-60.

Jackson RM, Rice DH. Acute bacterial sinusitis and diabetes mellitus. Otolaryngol Head Neck Surg . 1987 Nov;97(5):469-73.

Jarrett RF. Risk factors for Hodgkin's lymphoma by EBV status and significance of detection of EBV genomes in serum of patients with EBV-associated Hodgkin's lymphoma. Leuk Lymphoma . 2003;44 Suppl 3:S27-S32.

Jazirehi AR, Bonavida B. Resveratrol modifies the expression of apoptotic regulatory proteins and sensitizes non-Hodgkin's lymphoma and multiple myeloma cell lines to paclitaxel-induced apoptosis. Mol Cancer Ther . 2004 Jan;3(1):71-84.

Jetsrisuparb A, Wiangnon S et al. Rituximab combined with CHOP for successful treatment of aggressive recurrent, pediatric B-cell large cell non-Hodgkin's Lymphoma. J Pediatr Hematol Oncol . 2005 Apr;27(4):223-6.

Jimenez-Zepeda VH, Jimenez-Zepeda RJ. [Non-Hodgkin's lymphoma: biologic classification, diagnosis and treatment]. Gac Med Mex . 1998 Jul;134(4):443-63.

Jones DE. Fat is an immuno-regulatory issue. Hepatology . 2005 Oct;42(4):755-8.

Jose BO, Koerner P et al. Hodgkin's lymphoma in adults--clinical features. J Ky Med Assoc . 2005 Jan;103(1):15-7.

Kakizoe T. Chemoprevention of cancer--focusing on clinical trials. Jpn J Clin Oncol . 2003 Sep;33(9):421-42.

Kaplan LD. AIDS-associated lymphoma. Baillieres Clin Haematol . 1990 Jan;3(1):139-51.

Kato I, Koenig KL et al. History of antibiotic use and risk of non-Hodgkin's lymphoma (NHL). Int J Cancer . 2003 Oct 20;107(1):99-105.

Kato I, Koenig KL et al. Use of anti-inflammatory and non-narcotic analgesic drugs and risk of non-Hodgkin's lymphoma (NHL) (United States). Cancer Causes Control . 2002 Dec;13(10):965-74.

Katsuno Y, Koyama Y et al. Apoptosis-inducing activity of a driselase digest fraction of green tea residue. Biosci Biotechnol Biochem . 2001 Jan;65(1):198-201.

Kempf W, Kettelhack N et al. Topical and systemic retinoid therapy for cutaneous T-cell lymphoma. Hematol Oncol Clin North Am . 2003 Dec;17(6):1405-19.

Kohn LD, Wallace B et al. Is type 2 diabetes an autoimmune-inflammatory disorder of the innate immune system? Endocrinology . 2005 Oct;146(10):4189-91.

Krueger GR, Guenther A et al. Human herpesvirus-6 (HHV-6) in Hodgkin's disease: cellular expression of viral antigens as compared to oncogenes met and fes, tumor suppressor gene product p53, and interleukins 2 and 6. In Vivo . 1994 Jul;8(4):501-16.

Kuppers R, Schwering I et al. Biology of Hodgkin's lymphoma. Ann Oncol . 2002;13 Suppl 1:11-8.

Lagman R, Walsh D. Dangerous nutrition? Calcium, vitamin D, and shark cartilage nutritional supplements and cancer-related hypercalcemia. Support Care Cancer . 2003 Apr;11(4):232-5.

Laurie SA, Miller VA et al. Phase I study of green tea extract in patients with advanced lung cancer. Cancer Chemother Pharmacol . 2005 Jan;55(1):33-8.

Lavoie JC, Connors JM et al. High-dose chemotherapy and autologous stem cell transplantation for primary refractory or relapsed Hodgkin lymphoma: long-term outcome in the first 100 patients treated in Vancouver. Blood . 2005 May 3.

Lee WJ, Cantor KP et al. Non-Hodgkin's lymphoma among asthmatics exposed to pesticides. Int J Cancer . 2004 Aug 20;111(2):298-302.

Lenz G, Dreyling M et al. Immunochemotherapy with rituximab and cyclophosphamide, doxorubicin, vincristine, and prednisone significantly improves response and time to treatment failure, but not long-term outcome in patients with previously untreated mantle cell lymphoma: results of a prospective randomized trial of the German Low Grade Lymphoma Study Group (GLSG). J Clin Oncol . 2005 Mar 20;23(9):1984-92.

Lewington V. Development of 131I-tositumomab. Semin Oncol . 2005 Feb;32(1 Suppl 1):S50-S56.

Lim ST, Levine AM. Non-AIDS-defining cancers and HIV infection. Curr Infect Dis Rep . 2005 May;7(3):227-34.

Lister TA, Crowther D et al. Report of a committee convened to discuss the evaluation and staging of patients with Hodgkin's disease: Cotswolds meeting. J Clin Oncol . 1989 Nov;7(11):1630-6.

Litam P, Swan F et al. Prognostic value of serum beta-2 microglobulin in low-grade lymphoma. Ann Intern Med . 1991 May 15;114(10):855-60.

Lyman GH. A predictive model for neutropenia associated with cancer chemotherapy. Pharmacotherapy . 2000 Jul;20(7 Pt 2):104S-11S.

Macklis RM. Radioimmunotherapy as a Therapeutic Option for Non-Hodgkin's Lymphoma. Semin Radiat Oncol. 2007 Jul;17(3):176-83.

Mahrle G, Thiele B. Retinoids in cutaneous T cell lymphomas. Dermatologica . 1987;175 Suppl 1:145-50.

Maloney DG. Concepts in radiotherapy and immunotherapy: anti-CD20 mechanisms of action and targets. Semin Oncol . 2005 Feb;32(1 Suppl 1):S19-S26.

Martin S, Fischer C et al. LightCycler-based quantitative real-time PCR monitoring of patients with follicular lymphoma receiving rituximab in combination with conventional or high-dose cytotoxic chemotherapy. Eur J Haematol . 2005 Apr;74(4):282-92.

Mathiasen IS, Colston KW et al. EB 1089, a novel vitamin D analogue, has strong antiproliferative and differentiation inducing effects on cancer cells. J Steroid Biochem Mol Biol . 1993 Sep;46(3):365-71.

Mellibovsky L, Diez A et al. Long-standing remission after 25-OH D3 treatment in a case of chronic myelomonocytic leukaemia. Br J Haematol . 1993 Dec;85(4):811-2.

Meyskens FL, Jr., Kopecky KJ et al. Effects of vitamin A on survival in patients with chronic myelogenous leukemia: a SWOG randomized trial. Leuk Res . 1995 Sep;19(9):605-12.

Miyoshi N, Nakamura Y et al. Dietary ginger constituents, galanals A and B, are potent apoptosis inducers in Human T lymphoma Jurkat cells. Cancer Lett . 2003 Sep 25;199(2):113-9.

Mohammad RM, Al-Katib A et al. Genistein sensitizes diffuse large cell lymphoma to CHOP (cyclophosphamide, doxorubicin, vincristine, prednisone) chemotherapy. Mol Cancer Ther . 2003 Dec;2(12):1361-8.

Morgensztern D, Rosado M et al. Prevalence of hepatitis C infection in patients with non-Hodgkin's lymphoma in South Florida and review of the literature. Leuk Lymphoma . 2004 Dec;45(12):2459-64.

Mukai HY, Okoshi Y et al. Successful treatment of a patient with subcutaneous panniculitis-like T-cell lymphoma with high-dose chemotherapy and total body irradiation. Eur J Haematol . 2003 Jun;70(6):413-6.

Muller AM, Ihorst G et al. Epidemiology of non-Hodgkin's lymphoma (NHL): trends, geographic distribution, and etiology. Ann Hematol . 2005 Jan;84(1):1-12.

Nagy B, Mucsi I et al. Chemosensitizing effect of vitamin C in combination with 5-fluorouracil in vitro. In Vivo . 2003 May;17(3):289-92.

Nakai S, Masaki T et al. Diffuse large B-cell primary gastric lymphoma treated successfully with the CD20 monoclonal antibody (rituximab): A case with severe liver dysfunction due to liver cirrhosis and hepatocellular carcinoma. Oncol Rep . 2005 Jun;13(6):1065-8.

Natazuka T, Manabe Y et al. Association between non-insulin dependent diabetes mellitus and non-Hodgkin's lymphoma. BMJ . 1994 Nov 12;309(6964):1269.

Nicot C. Current views in HTLV-I-associated adult T-cell leukemia/lymphoma. Am J Hematol . 2005 Mar;78(3):232-9.

Noronha V, Shafi NQ et al. Primary non-Hodgkin's lymphoma of the liver. Crit Rev Oncol Hematol . 2005 Mar;53(3):199-207.

Ogilvie GK, Fettman MJ et al. Effect of fish oil, arginine, and doxorubicin chemotherapy on remission and survival time for dogs with lymphoma: a double-blind, randomized placebo-controlled study. Cancer . 2000 Apr 15;88(8):1916-28.

Park JW, Choi YJ et al. Chemopreventive agent resveratrol, a natural product derived from grapes, reversibly inhibits progression through S and G2 phases of the cell cycle in U937 cells. Cancer Lett . 2001 Feb 10;163(1):43-9.

Pasqualucci L, Bereschenko O et al. Molecular pathogenesis of non-Hodgkin's lymphoma: the role of Bcl-6. Leuk Lymphoma . 2003;44 Suppl 3:S5-12.

Pedersen LM, Klausen TW et al. Early changes in serum IL-6 and VEGF levels predict clinical outcome following first-line therapy in aggressive non-Hodgkin's lymphoma. Ann Hematol . 2005 Apr 15.

Pisters KM, Newman RA et al. Phase I trial of oral green tea extract in adult patients with solid tumors. J Clin Oncol . 2001 Mar 15;19(6):1830-8.

Plat J, Mensink RP. Food components and immune function. Curr Opin Lipidol . 2005 Feb;16(1):31-7.

Plosker GL, Figgitt DP. Rituximab: a review of its use in non-Hodgkin's lymphoma and chronic lymphocytic leukaemia. Drugs . 2003;63(8):803-43.

Prasad SB, Giri A et al. Use of subtherapeutical dose of cisplatin and vitamin C against murine Dalton's lymphoma. Pol J Pharmacol Pharm . 1992 Jul;44(4):383-91.

Quintana PJ, Delfino RJ et al. Adipose tissue levels of organochlorine pesticides and polychlorinated biphenyls and risk of non-Hodgkin's lymphoma. Environ Health Perspect . 2004 Jun;112(8):854-61.

Ranjan D, Johnston TD et al. Enhanced apoptosis mediates inhibition of EBV-transformed lymphoblastoid cell line proliferation by curcumin. J Surg Res . 1999 Nov;87(1):1-5.

Rigacci L, Carrai V et al. Combined chemotherapy with carmustine, doxorubicin, etoposide, vincristine, and cyclophosphamide plus mitoxantrone, cytarabine and methotrexate with citrovorum factor for the treatment of aggressive non-Hodgkin lymphoma: a long-term follow-up study. Cancer . 2005 Mar 1;103(5):970-7.

Riley MB, Gordon LI. Efficacy and safety of radioimmunotherapy with yttrium 90 ibritumomab tiuxetan (Zevalin). Semin Oncol Nurs. 2004 Feb;20(1 Suppl 1):8-13.

Rossing N. [Raw food against cancer. A report from a study done by the Society for Alternative Medicine]. Ugeskr Laeger . 1988 Mar 7;150(10):613-5.

Russell RM. The vitamin A spectrum: from deficiency to toxicity. Am J Clin Nutr . 2000 Apr;71(4):878-84.

Scharfenberg K, Wagner R et al. The cytotoxic effect of ajoene, a natural product from garlic, investigated with different cell lines. Cancer Lett . 1990 Sep;53(2-3):103-8.

Schneider RJ, Seibert K et al. Prognostic significance of serum lactate dehydrogenase in malignant lymphoma. Cancer . 1980 Jul 1;46(1):139-43.

Seve P, Renaudier P et al. Hepatitis C virus infection and B-cell non-Hodgkin's lymphoma: a cross-sectional study in Lyon, France. Eur J Gastroenterol Hepatol . 2004 Nov;16(12):1361-5.

Smedby KE, Akerman M et al. Malignant lymphomas in coeliac disease: evidence of increased risks for lymphoma types other than enteropathy-type T cell lymphoma. Gut . 2005 Jan;54(1):54-9.

Sonet A, Theate I et al. Clinical and pathological features of 14 non-Hodgkin's lymphomas associated with coeliac disease. Acta Clin Belg . 2004 May;59(3):143-51.

Tajima M. [Chronic cardiotoxicity of anthracycline derivatives and possible prevention by coenzyme Q10]. Gan No Rinsho . 1984 Jul;30(9 Suppl):1211-6.

Thompson LD, Fisher SI et al. HIV-associated Hodgkin lymphoma: a clinicopathologic and immunophenotypic study of 45 cases. Am J Clin Pathol . 2004 May;121(5):727-38.

Tsubaki K, Horiuchi A et al. [Investigation of the preventive effect of CoQ10 against the side-effects of anthracycline antineoplastic agents]. Gan To Kagaku Ryoho . 1984 Jul;11(7):1420-7.

Tulpule A, Levine A. AIDS-related lymphoma. Blood Rev . 1999 Sep;13(3):147-50.

Vallisa D, Bernuzzi P et al. Role of anti-hepatitis C virus (HCV) treatment in HCV-related, low-grade, B-cell, non-Hodgkin's lymphoma: a multicenter Italian experience. J Clin Oncol . 2005 Jan 20;23(3):468-73.

Vamvakas EC. Allogeneic blood transfusion as a risk factor for the subsequent development of non-Hodgkin's lymphoma. Transfus Med Rev . 2000 Jul;14(3):258-68.

van Loghem JJ. [Raw food to cure cancer.]. Ned Tijdschr Geneeskd . 1951 Feb 10;95(6):482-3.

Waddell BL, Zahm SH et al. Agricultural use of organophosphate pesticides and the risk of non-Hodgkin's lymphoma among male farmers (United States). Cancer Causes Control . 2001 Aug;12(6):509-17.

Walle T, Hsieh F et al. High absorption but very low bioavailability of oral resveratrol in humans. Drug Metab Dispos . 2004 Dec;32(12):1377-82.

Wang SQ. [Electrocardiogram analysis of adriamycin cardiotoxicity in 160 cases]. Zhonghua Zhong Liu Za Zhi . 1991 Jan;13(1):71-3.

Ward MH, Mark SD et al. Drinking water nitrate and the risk of non-Hodgkin's lymphoma. Epidemiology . 1996 Sep;7(5):465-71.

Weisenburger DD. Environmental epidemiology of non-Hodgkin's lymphoma in eastern Nebraska. Am J Ind Med . 1990;18(3):303-5.

Wieder R, Novick SC et al. Pharmacokinetics and safety of ILX23-7553, a non-calcemic-vitamin D3 analogue, in a phase I study of patients with advanced malignancies. Invest New Drugs . 2003 Nov;21(4):445-52.

Wiseman GA, Witzig TE. Yttrium-90 (90Y ibritumomab tiuxetan (Zevalin) induces long-term durable responses in patients with relapsed or refractory B-Cell non-Hodgkin's Lymphoma. Cancer Biother Radiopharm . 2005 Apr;20(2):185-8.

Witzig TE, Gordon LI, et al. Randomized controlled trial of yttrium-90-labeled ibritumomab tiuxetan radioimmunotherapy versus rituximab immunotherapy for patients with relapsed or refractory low-grade, follicular, or transformed B-cell non-Hodgkin's lymphoma. J Clin Oncol. 2002 May 15;20(10):2453-63.

Witzig TE, Molina A, et al. Long-term responses in patients with recurring or refractory B-cell non-Hodgkin lymphoma treated with yttrium 90 ibritumomab tiuxetan. Cancer. 2007 May 1;109(9):1804-10.

Wotherspoon AC. Gastric lymphoma of mucosa-associated lymphoid tissue and Helicobacter pylori. Annu Rev Med . 1998;49:289-99.

Wu Y, Chen Y et al. Anticancer activities of curcumin on human Burkitt's lymphoma. Zhonghua Zhong Liu Za Zhi . 2002a Jul;24(4):348-52.

Wu Y, Chen Y et al. Anticancer activities of curcumin on human Burkitt's lymphoma. Zhonghua Zhong Liu Za Zhi . 2002c Jul;24(4):348-52.

Wu Y, Chen Y et al. Anticancer activities of curcumin on human Burkitt's lymphoma. Zhonghua Zhong Liu Za Zhi . 2002b Jul;24(4):348-52.

Wu Y, Chen Y et al. Anticancer activities of curcumin on human Burkitt's lymphoma. Zhonghua Zhong Liu Za Zhi . 2002d Jul;24(4):348-52.

Younes A. New treatment strategies for aggressive lymphoma. Semin Oncol . 2004 Dec;31(6 Suppl 15):10-3.

Zhang C, Duvic M. Retinoids: therapeutic applications and mechanisms of action in cutaneous T-cell lymphoma. Dermatol Ther . 2003;16(4):322-30.

Zhang S, Hunter DJ et al. Dietary fat and protein in relation to risk of non-Hodgkin's lymphoma among women. J Natl Cancer Inst . 1999 Oct 20;91(20):1751-8.

Zhang SM, Hunter DJ et al. Intakes of fruits, vegetables, and related nutrients and the risk of non-Hodgkin's lymphoma among women. Cancer Epidemiol Biomarkers Prev . 2000 May;9(5):477-85.

Zheng T, Holford TR et al. Diet and nutrient intakes and risk of non-Hodgkin's lymphoma in Connecticut women. Am J Epidemiol . 2004 Mar 1;159(5):454-66.